Drugs / liposome dispersion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07375498 | Aug → Dec 2026 expected | — | Cristália Produtos Químicos Farmacêuticos Ltda. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liposome dispersion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07375498 ↗ |
| Route | Intravenous | “intravenous liposomal dispersion product” NCT07375498 ↗ |